Plan objectives, create tools and finally transfer knowledge
On a tissue engineering product the clinical outcom is the fundamental part of the product. But scientific assumptions, methods, clinical targets and survey are the basics on a correct clinical disclosure.
Our staff includes professionals who have been working in tissue engineering market for many years, with significant management experiences in the clinical use of autologous biological components, including stromal vascular fraction from adipose tissue, bone marrows and blood cells. Besides a unique experience in processing and clinicial experience in allogeneic fibrobalsts and keratonocytes for wound healing.
Of great importance was the Italian experience: the use of concentrations of autologous monocytes in critical limb ischemia and diabetic foot is an early model of tissue engineering therapy that has achieved a systematic use in clinical practice.
Our network includes partnership in Europe, Middle East, South America and China.